PERSPECTA

News from every angle

← Back to headlines

Spyre Therapeutics Announces Positive UC Treatment Trial Results, Stock Soars

Spyre Therapeutics (SYRE) announced stellar results from its ulcerative colitis (UC) treatment trial, causing its stock to reach a four-year high.

14 Apr, 00:46 — 14 Apr, 00:46
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual134d ago

Spyre (SYRE) Announces Stellar UC Treatment Trial, Hits 4-Year High

Read full article →

Related Stories

Treasury Secretary Bessent's Bond Strategy Faces Scrutiny and Criticism

4h ago

Richtech Robotics Announces Stock Repurchase Program, Shares Rise

8h ago

Apollo, KKR, and IFM Investors Finalists in AB Ports Stake Sale

8h ago

Gold Fields Returns R8 Billion to Shareholders Amidst Earnings Jump

9h ago